Protamine-stabilized RNA as an ex vivo stimulant of primary human dendritic cell subsets.

Protamine-stabilized RNA as an ex vivo stimulant of primary human dendritic cell subsets.

Item
http://www.wikidata.org/entity/Q41835523
RNA-Based Vaccines in Cancer ImmunotherapyHarnessing RNA sequencing for global, unbiased evaluation of two new adjuvants for dendritic-cell immunotherapy.Human blood myeloid and plasmacytoid dendritic cells cross activate each other and synergize in inducing NK cell cytotoxicity.Modified mRNA as a therapeutic tool to induce cardiac regeneration in ischemic heart disease.Human CD1c(+) DCs are critical cellular mediators of immune responses induced by immunogenic cell death.Electroporated Antigen-Encoding mRNA Is Not a Danger Signal to Human Mature Monocyte-Derived Dendritic Cells.Primary Human Blood Dendritic Cells for Cancer Immunotherapy-Tailoring the Immune Response by Dendritic Cell Maturation.Generation of Immunostimulating 130 nm Protamine-RNA nanoparticles.Latest development on RNA-based drugs and vaccines.Human Dendritic Cell Subsets Undergo Distinct Metabolic Reprogramming for Immune Response
P2860

Protamine-stabilized RNA as an ex vivo stimulant of primary human dendritic cell subsets.

Item
http://www.wikidata.org/entity/Q41835523
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Protamine-stabilized RNA as an ex vivo stimulant of primary human dendritic cell subsets.
@en
type
label
Protamine-stabilized RNA as an ex vivo stimulant of primary human dendritic cell subsets.
@en
prefLabel
Protamine-stabilized RNA as an ex vivo stimulant of primary human dendritic cell subsets.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P6179
P698
P932
P356
P1433
P1476
Protamine-stabilized RNA as an ex vivo stimulant of primary human dendritic cell subsets.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P6179
P698
P932